1109 related articles for article (PubMed ID: 16398774)
1. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L
BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
[TBL] [Abstract][Full Text] [Related]
2. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
Incerti M; Ghidini A; Korker V; Pezzullo JC
Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
[TBL] [Abstract][Full Text] [Related]
3. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Carey JC; Klebanoff MA; Hauth JC; Hillier SL; Thom EA; Ernest JM; Heine RP; Nugent RP; Fischer ML; Leveno KJ; Wapner R; Varner M
N Engl J Med; 2000 Feb; 342(8):534-40. PubMed ID: 10684911
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET study.
Ugwumadu A; Yanamandra N; Hay P
BJOG; 2006 Jul; 113(7):851-2. PubMed ID: 16827776
[No Abstract] [Full Text] [Related]
5. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study by Shennan et al.
Lamont RF; Dragovic B
BJOG; 2006 Jul; 113(7):850-1; author reply 851. PubMed ID: 16827775
[No Abstract] [Full Text] [Related]
6. Fetal fibronectin test predicts delivery before 30 weeks of gestation in high risk women, but increases anxiety.
Shennan A; Jones G; Hawken J; Crawshaw S; Judah J; Senior V; Marteau T; Chinn S; Poston L
BJOG; 2005 Mar; 112(3):293-8. PubMed ID: 15713142
[TBL] [Abstract][Full Text] [Related]
7. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis.
Hauth JC; Goldenberg RL; Andrews WW; DuBard MB; Copper RL
N Engl J Med; 1995 Dec; 333(26):1732-6. PubMed ID: 7491136
[TBL] [Abstract][Full Text] [Related]
8. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
McParland PC; Kenyon S; Bell SC; Taylor DJ
BJOG; 2006 Aug; 113(8):976; author reply 976-7. PubMed ID: 16907946
[No Abstract] [Full Text] [Related]
9. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy.
Donders GG; Van Calsteren K; Bellen G; Reybrouck R; Van den Bosch T; Riphagen I; Van Lierde S
BJOG; 2009 Sep; 116(10):1315-24. PubMed ID: 19538417
[TBL] [Abstract][Full Text] [Related]
10. Fetal fibronectin as a predictor of spontaneous preterm labour in asymptomatic women with a cervical cerclage.
Duhig KE; Chandiramani M; Seed PT; Briley AL; Kenyon AP; Shennan AH
BJOG; 2009 May; 116(6):799-803. PubMed ID: 19432568
[TBL] [Abstract][Full Text] [Related]
11. Treatment of bacterial vaginosis does not reduce preterm birth among high-risk asymptomatic women in fetal fibronectin positive patients.
Briery CM; Chauhan SP; Magann EF; Cushman JL; Morrison JC
J Miss State Med Assoc; 2011 Mar; 52(3):72-5. PubMed ID: 21476464
[TBL] [Abstract][Full Text] [Related]
12. Does oral metronidazole prevent preterm delivery in normal-risk pregnant women with asymptomatic bacterial vaginosis (BV)?
Lazar PA
J Fam Pract; 2000 Jun; 49(6):495-6. PubMed ID: 10923545
[No Abstract] [Full Text] [Related]
13. Quantitative fetal fibronectin screening in asymptomatic high-risk patients and the spectrum of risk for recurrent preterm delivery.
Kurtzman J; Chandiramani M; Briley A; Poston L; Das A; Shennan A
Am J Obstet Gynecol; 2009 Mar; 200(3):263.e1-6. PubMed ID: 19254585
[TBL] [Abstract][Full Text] [Related]
14. A randomized multicenter study to determine the efficacy of activity restriction for preterm labor management in patients testing negative for fetal fibronectin.
Elliott JP; Miller HS; Coleman S; Rhea D; Abril D; Hallbauer K; Istwan NB; Stanziano GJ
J Perinatol; 2005 Oct; 25(10):626-30. PubMed ID: 16107874
[TBL] [Abstract][Full Text] [Related]
15. Is a change in the vaginal flora associated with an increased risk of preterm birth?
Carey JC; Klebanoff MA
Am J Obstet Gynecol; 2005 Apr; 192(4):1341-6; discussion 1346-7. PubMed ID: 15846235
[TBL] [Abstract][Full Text] [Related]
16. Fetal fibronectin and bacterial vaginosis are associated with preterm birth in women who are symptomatic for preterm labor.
Stevens AO; Chauhan SP; Magann EF; Martin RW; Bofill JA; Cushman JL; Morrison JC
Am J Obstet Gynecol; 2004 Jun; 190(6):1582-7; discussion 1587-9. PubMed ID: 15284741
[TBL] [Abstract][Full Text] [Related]
17. Bacterial vaginosis in pregnancy and efficacy of short-course oral metronidazole treatment: a randomized controlled trial.
McDonald HM; O'Loughlin JA; Vigneswaran R; Jolley PT; McDonald PJ
Obstet Gynecol; 1994 Sep; 84(3):343-8. PubMed ID: 8058228
[TBL] [Abstract][Full Text] [Related]
18. Bacterial vaginosis in a cohort of Danish pregnant women: prevalence and relationship with preterm delivery, low birthweight and perinatal infections.
Svare JA; Schmidt H; Hansen BB; Lose G
BJOG; 2006 Dec; 113(12):1419-25. PubMed ID: 17010117
[TBL] [Abstract][Full Text] [Related]
19. "Blind" vaginal fetal fibronectin as a predictor of spontaneous preterm delivery.
Roman AS; Koklanaris N; Paidas MJ; Mulholland J; Levitz M; Rebarber A
Obstet Gynecol; 2005 Feb; 105(2):285-9. PubMed ID: 15684153
[TBL] [Abstract][Full Text] [Related]
20. TOCOX--a randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk.
Groom KM; Shennan AH; Jones BA; Seed P; Bennett PR
BJOG; 2005 Jun; 112(6):725-30. PubMed ID: 15924527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
